These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
461 related articles for article (PubMed ID: 30047626)
1. Overexpression of S100A13 protein is associated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer. Miao S; Qiu T; Zhao Y; Wang H; Sun X; Wang Y; Xuan Y; Qin Y; Jiao W Thorac Cancer; 2018 Sep; 9(9):1136-1144. PubMed ID: 30047626 [TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis. Han H; Silverman JF; Santucci TS; Macherey RS; d'Amato TA; Tung MY; Weyant RJ; Landreneau RJ Ann Surg Oncol; 2001; 8(1):72-9. PubMed ID: 11206229 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of Ang-2 mRNA in non-small cell lung cancer: association with angiogenesis and poor prognosis. Takanami I Oncol Rep; 2004 Oct; 12(4):849-53. PubMed ID: 15375511 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of metastasis-associated protein 1 is significantly correlated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer. Li SH; Tian H; Yue WM; Li L; Li WJ; Chen ZT; Hu WS; Zhu YC; Qi L Ann Surg Oncol; 2011 Jul; 18(7):2048-56. PubMed ID: 21290196 [TBL] [Abstract][Full Text] [Related]
5. GOLPH3, a good prognostic indicator in early-stage NSCLC related to tumor angiogenesis. Lu M; Tian Y; Yue WM; Li L; Li SH; Qi L; Hu WS; Gao C; Si LB; Tian H Asian Pac J Cancer Prev; 2014; 15(14):5793-8. PubMed ID: 25081702 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-37 suppresses tumor growth through inhibition of angiogenesis in non-small cell lung cancer. Ge G; Wang A; Yang J; Chen Y; Yang J; Li Y; Xue Y J Exp Clin Cancer Res; 2016 Jan; 35():13. PubMed ID: 26791086 [TBL] [Abstract][Full Text] [Related]
7. Elevated expression of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM-1) is associated with increased angiogenic potential in non-small-cell lung cancer. Dango S; Sienel W; Schreiber M; Stremmel C; Kirschbaum A; Pantel K; Passlick B Lung Cancer; 2008 Jun; 60(3):426-33. PubMed ID: 18215438 [TBL] [Abstract][Full Text] [Related]
8. [Vascular endothelial growth factor expression and microvessel density in stage I-II non-small cell lung cancer and their prognostic significances]. Zhu ZH; Rong TH; Zeng CG; Wu QL; Ma Y; Huang XP; Li BJ; Zhang PY; Zhao JM; Hu W; Zhang SY; Yu H; Ma GW; Zhang LJ; Wen ZS; Fu JH; Long H Ai Zheng; 2005 Jul; 24(7):865-9. PubMed ID: 16004817 [TBL] [Abstract][Full Text] [Related]
9. [Expression of CD82/KAI1 and HIF-1α in non-small cell lung cancer and their relationship to vasculogenic mimicry]. Wu S; Cheng Z; Yu L; Song W; Tao Y Zhongguo Fei Ai Za Zhi; 2011 Dec; 14(12):918-25. PubMed ID: 22152691 [TBL] [Abstract][Full Text] [Related]
10. Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome. Zhang L; Chen J; Ke Y; Mansel RE; Jiang WG Int J Mol Med; 2006 May; 17(5):937-44. PubMed ID: 16596284 [TBL] [Abstract][Full Text] [Related]
11. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer. De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780 [TBL] [Abstract][Full Text] [Related]
12. The Prognostic Effect of MAC30 Expression on Patients With Non-Small Cell Lung Cancer Receiving Adjuvant Chemotherapy. Ding H; Gui X; Lin X; Chen R; Ma T; Sheng Y; Cai H; Fen Y Technol Cancer Res Treat; 2017 Oct; 16(5):645-653. PubMed ID: 27688262 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of LAPTM4B is correlated with tumor angiogenesis and poor prognosis in non-small cell lung cancer. Tang H; Tian H; Yue W; Li L; Li S; Gao C; Si L; Qi L; Lu M Med Oncol; 2014 Jun; 31(6):974. PubMed ID: 24816841 [TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer. Mineo TC; Ambrogi V; Baldi A; Rabitti C; Bollero P; Vincenzi B; Tonini G J Clin Pathol; 2004 Jun; 57(6):591-7. PubMed ID: 15166262 [TBL] [Abstract][Full Text] [Related]
15. The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer. Li Z; Maeda D; Yoshida M; Umakoshi M; Nanjo H; Shiraishi K; Saito M; Kohno T; Konno H; Saito H; Minamiya Y; Goto A Lung Cancer; 2018 Sep; 123():127-135. PubMed ID: 30089583 [TBL] [Abstract][Full Text] [Related]
16. Upregulation of Nuclear Heat Shock Factor 1 Contributes to Tumor Angiogenesis and Poor Survival in Patients With Non-Small Cell Lung Cancer. Cui J; Tian H; Chen G Ann Thorac Surg; 2015 Aug; 100(2):465-72. PubMed ID: 26095102 [TBL] [Abstract][Full Text] [Related]
17. MDK Protein Overexpression Correlates with the Malignant Status and Prognosis of Non-small Cell Lung Cancer. Yuan K; Chen Z; Li W; Gao CE; Li G; Guo G; Yang Y; Ai Y; Wu L; Zhang M Arch Med Res; 2015 Nov; 46(8):635-41. PubMed ID: 26656665 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of immunohistochemical expressions of p53, HER-2/neu, and bcl-2 in stage I non-small-cell lung cancer. Han H; Landreneau RJ; Santucci TS; Tung MY; Macherey RS; Shackney SE; Sturgis CD; Raab SS; Silverman JF Hum Pathol; 2002 Jan; 33(1):105-10. PubMed ID: 11823980 [TBL] [Abstract][Full Text] [Related]
19. Increased high-mobility group A2 correlates with lymph node metastasis and prognosis of non-small cell lung cancer. Guo X; Shi J; Wen Y; Li M; Li Q; Li X; Li J Cancer Biomark; 2018 Feb; 21(3):547-555. PubMed ID: 29278873 [TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer. Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]